Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human FGF 1 Protein, Sf9 (AC1723)
Cat.#: ACPP-1723
Specifications
Despition FGF 1 Human Recombinant, Sf9 Tag SIZE 2 µg Sequence Met-Phe-Asn-Leu-Pro. Purity > 95.0% (SDS-PAGE) Form Sterile Filtered liquid formulation. Storage Store at 4°C for 2-4 weeks. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1076 Synaptophysin Blocking Peptide (AC1076) 250 µg inquiry ACPP-1390 Human GDF11 Protein, His (AC1390) 5 µg inquiry ACPP-1236 SOX2 Blocking Peptide (AC1236) 250 µg inquiry ACPP-1464 Human ERLIN2 Protein (AC1464) 5 µg inquiry ACPP-1416 Human VAMP1 Protein (AC1416) 20 µg inquiry ACPP-1743 Human SCG5 Protein (AC1743) 2 µg inquiry ACPP-1099 Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) 10 µg inquiry ACPP-1507 Human SDC4 Protein (AC1507) 2 µg inquiry ACPP-1806 Human SCGN Protein (AC1806) 2 µg inquiry ACPP-1461 Human Luteinizing Hormone Protein (AC1461) 100 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket